Eden Biodesign expands Research Triangle Park Facility
Eden Biodesign Ltd. confirmed its expansion plans for Eden Biodesign, Inc., the Group's US subsidiary, with the announcement of a facility in the Research Triangle Park, North Carolina.
Eden Biodesign, Inc., will offer a range of cell line/strain development and early process development services. Eden Biodesign provides services in support of all major biopharmaceutical production technologies (mammalian, microbial and viral) and offers a "toolbox" of expression technologies, some via collaboration with partner companies.
"The selection of North Carolina's world-renowned Research Triangle Park signifies the strategic importance of the North American market to Eden Biodesign", said Dr. Crawford Brown, Chief Executive Officer, Eden Biodesign. "By establishing a subsidiary in the United States we are making it easier for clients to access Eden's proven expertise and inspected cGMP manufacturing facilities and confirming Eden's position as a recognized global player in the contract biopharmaceutical manufacturing services market".
Eden Biodesign is further cementing its commitment to the North American market with the recent appointment of Michael Faughnan as Business Development Director, who will be supporting the Company's expansion into the North American market from Southern California. The Company is actively developing technology and marketing collaborations with industry leaders throughout North America.
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.